Yap-Hang Will Chan

18PUBLICATIONS
45CO-AUTHORS
Molecular medicineGenomicsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersCardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|May 18, 2026
Author's Reply to: "Comment on: Colchicine for the Secondary Prevention of Cardiovascular Diseases: A Cumulative-Dose Meta-analysis of Randomized Controlled Trials Including 31,397 Subjects Worldwide".

|May 15, 2026
Population-scale genomic medicine with the Hong Kong Genome Project.

|Mar 17, 2026
Comparing GLP-1 agonists versus other weight loss interventions on risk of atrial fibrillation recurrence after catheter ablation: a meta-analysis.

Hoi-Ying Li, Gregory Y H Lip, Tsz-Kwan Chan

|Jan 26, 2026
GLP-1 Receptor Agonists and Risk of Optic Nerve or Vision-Threatening Events in Patients With Type 2 Diabetes or Cardiometabolic Diseases: A Meta-analysis of Randomized Controlled Trials.

Hoi-Ying Li, Tsz-Kwan Chan, Kendrick Co Shih

|Sep 30, 2025
Trimetazidine Is Associated With Ameliorated Stroke Risk in Patients With Both Ischemic Heart Disease and Atrial Fibrillation.

Yuen-Ting Cheng, Gregory Y H Lip, Bernard M Y Cheung

|Sep 01, 2025
Colchicine for the Secondary Prevention of Cardiovascular Diseases: A Cumulative-Dose Meta-analysis of Randomized Controlled Trials including 31,397 Subjects Worldwide.

Hoi-Ying Li, Joseph Cheriyan, Tsz-Kwan Chan

Pageof 3

Frequent Collaborators

7 joint publications

Hung-Fat Tse

5 joint publications

Kai-Hang Yiu

3 joint publications

Jojo Siu-Han Hai

3 joint publications

Shiu-Lun Au Yeung